{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:14:12Z","timestamp":1726506852397},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,9]]},"DOI":"10.7759\/cureus.27817","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:45:22Z","timestamp":1660056322000},"source":"Crossref","is-referenced-by-count":1,"title":["Outcomes of Transcutaneous Retrobulbar Amphotericin B in Rhino-Orbital-Cerebral Mucormycosis Among Patients Recovering From COVID-19: A Preliminary Experience"],"prefix":"10.7759","author":[{"given":"Shivani","family":"Sinha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya B","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhi","family":"Kusumesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragati","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibhuti P","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel A","year":"2020","unstructured":"Patel A, Kaur H, Xess I, et al.. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Clin Microbiol Infect. 2020, 26:944.e9-944.e15. 10.1016\/j.cmi.2019.11.021","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India","volume":"15","author":"Singh AK","year":"2021","unstructured":"Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021, 15:102146. 10.1016\/j.dsx.2021.05.019","journal-title":"Diabetes Metab Syndr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2021.1990351","article-title":"Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review","volume":"41","author":"Nair AG","year":"2022","unstructured":"Nair AG, Dave TV. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review. Orbit. 2022, 41:275-86. 10.1080\/01676830.2021.1990351","journal-title":"Orbit"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar S","year":"2021","unstructured":"Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021, 69:1002-4. 10.4103\/ijo.IJO_3763_20","journal-title":"Indian J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000488","article-title":"The role of adjunctive therapies in the management of invasive sino-orbital infection","volume":"31","author":"Colon-Acevedo B","year":"2015","unstructured":"Colon-Acevedo B, Kumar J, Richard MJ, Woodward JA. The role of adjunctive therapies in the management of invasive sino-orbital infection. Ophthalmic Plast Reconstr Surg. 2015, 31:401-5. 10.1097\/IOP.0000000000000488","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2021.05.025","article-title":"Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin B for invasive fungal rhino-orbital sinusitis","volume":"237","author":"Ashraf DC","year":"2022","unstructured":"Ashraf DC, Idowu OO, Hirabayashi KE, et al.. Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin B for invasive fungal rhino-orbital sinusitis. Am J Ophthalmol. 2022, 237:299-309. 10.1016\/j.ajo.2021.05.025","journal-title":"Am J Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2356_21","article-title":"Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: our experience","volume":"70","author":"Ramamurthy LB","year":"2022","unstructured":"Ramamurthy LB, Bhandari R, Kanakpur S, Thejaswini P. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: our experience. Indian J Ophthalmol. 2022, 70:1019-24. 10.4103\/ijo.IJO_2356_21","journal-title":"Indian J Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code mucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar SG","year":"2021","unstructured":"Honavar SG. Code mucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol. 2021, 69:1361-5. 10.4103\/ijo.IJO_1165_21","journal-title":"Indian J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.36348\/sjmps.2022.v08i03.004","article-title":"COVID 19 associated rhino-orbital-cerebral mucormycosis-clinicoetiological profile and management outcome of patients in tertiary eye care centre in northern India","volume":"8","author":"Chawla U","year":"2022","unstructured":"Chawla U, Chadha G, Anand N, et al.. COVID 19 associated rhino-orbital-cerebral mucormycosis-clinicoetiological profile and management outcome of patients in tertiary eye care centre in northern India. Saudi J Med Pharm Sci. 2022, 8:120-33. 10.36348\/sjmps.2022.v08i03.004","journal-title":"Saudi J Med Pharm Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002030","article-title":"Clinical presentations, management and outcomes of rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19: a multi-centric study","volume":"37","author":"Dave TV","year":"2021","unstructured":"Dave TV, Gopinathan Nair A, Hegde R, et al.. Clinical presentations, management and outcomes of rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19: a multi-centric study. Ophthalmic Plast Reconstr Surg. 2021, 37:488-95. 10.1097\/IOP.0000000000002030","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen M","year":"2021","unstructured":"Sen M, Honavar SG, Bansal R, et al.. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021, 69:1670-92. 10.4103\/ijo.IJO_1565_21","journal-title":"Indian J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2021.1960382","article-title":"Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients","volume":"40","author":"Nair AG","year":"2021","unstructured":"Nair AG, Adulkar NG, D'Cunha L, et al.. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients. Orbit. 2021, 40:499-504. 10.1080\/01676830.2021.1960382","journal-title":"Orbit"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103220","article-title":"COVID associated mucormycosis: a preliminary study from a dedicated COVID Hospital in Delhi","volume":"43","author":"Meher R","year":"2022","unstructured":"Meher R, Wadhwa V, Kumar V, et al.. COVID associated mucormycosis: a preliminary study from a dedicated COVID Hospital in Delhi. Am J Otolaryngol. 2022, 43:103220. 10.1016\/j.amjoto.2021.103220","journal-title":"Am J Otolaryngol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: mucormycosis in COVID-19 times","volume":"69","author":"Ravani SA","year":"2021","unstructured":"Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021, 69:1563-8. 10.4103\/ijo.IJO_310_21","journal-title":"Indian J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_2366_21.","article-title":"A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis","volume":"2022","author":"Mani S","unstructured":"Mani S,Thirunavukkarasu A..  A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis. Indian J Ophthalmol. 2022:1013-1018. 10.4103\/ijo.IJO_2366_21.","journal-title":"Indian J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:298. 10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash H","year":"2019","unstructured":"Prakash H, Ghosh AK, Rudramurthy SM, et al.. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019, 57:395-402. 10.1093\/mmy\/myy060","journal-title":"Med Mycol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-021-02825-0","article-title":"Risk factors for procurence of mucormycosis and its manifestations post Covid-19: a single arm retrospective unicentric clinical study","author":"Gupta S","year":"2021","unstructured":"Gupta S, Ahuja P. Risk factors for procurence of mucormycosis and its manifestations post Covid-19: a single arm retrospective unicentric clinical study. Indian J Otolaryngol Head Neck Surg. 2021, 1-8. 10.1007\/s12070-021-02825-0","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-021-07010-1","article-title":"Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control","volume":"279","author":"Mitra S","year":"2022","unstructured":"Mitra S, Janweja M, Sengupta A. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control. Eur Arch Otorhinolaryngol. 2022, 279:2417-22. 10.1007\/s00405-021-07010-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246307","article-title":"Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis","volume":"15","author":"Singh P","year":"2022","unstructured":"Singh P, Gupta A, Sanepalli SR, Raj A. Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis. BMJ Case Rep. 2022, 15:e246307. 10.1136\/bcr-2021-246307","journal-title":"BMJ Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2020.100771","article-title":"Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B","volume":"19","author":"Safi M","year":"2020","unstructured":"Safi M, Ang MJ, Patel P, Silkiss RZ. Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B. Am J Ophthalmol Case Rep. 2020, 19:100771. 10.1016\/j.ajoc.2020.100771","journal-title":"Am J Ophthalmol Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/103510-outcomes-of-transcutaneous-retrobulbar-amphotericin-b-in-rhino-orbital-cerebral-mucormycosis-among-patients-recovering-from-covid-19-a-preliminary-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:53Z","timestamp":1707507413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/103510-outcomes-of-transcutaneous-retrobulbar-amphotericin-b-in-rhino-orbital-cerebral-mucormycosis-among-patients-recovering-from-covid-19-a-preliminary-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.27817","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,9]]}}}